OIKOS HOLDINGS LLC - Q4 2017 holdings

$172 Million is the total value of OIKOS HOLDINGS LLC's 9 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was - .

 Value Shares↓ Weighting
MLNT NewMELINTA THERAPEUTICS INC$106,325,0006,729,459
+100.0%
61.65%
FLOT NewISHARES TRfltg rate nt etf$24,410,000480,315
+100.0%
14.15%
FG NewFGL HLDGS$15,105,0001,500,000
+100.0%
8.76%
SHPG NewSHIRE PLCsponsored adr$7,973,00051,400
+100.0%
4.62%
FGWS NewFGL HLDGScall$7,553,000750,000
+100.0%
4.38%
KREF NewKKR REAL ESTATE FIN TR INC$4,572,000228,491
+100.0%
2.65%
ALXN NewALEXION PHARMACEUTICALS INC$2,954,00024,700
+100.0%
1.71%
BXMT NewBLACKSTONE MTG TR INC$2,896,00090,000
+100.0%
1.68%
SNSS NewSUNESIS PHARMACEUTICALS INC$673,000182,395
+100.0%
0.39%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS13Q3 202382.8%
VANGUARD INDEX FDS11Q3 202342.2%
VANGUARD STAR FDS10Q3 202332.6%
VANGUARD SCOTTSDALE FDS9Q3 20237.4%
ISHARES TR8Q3 201962.5%
FGL HLDGS8Q3 201939.0%
ISHARES TR8Q3 202316.0%
VANGUARD INTL EQUITY INDEX F8Q3 20234.0%
VANGUARD INDEX FDS7Q3 202313.7%
MELINTA THERAPEUTICS INC5Q4 201864.1%

View OIKOS HOLDINGS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
OIKOS HOLDINGS LLC Q4 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MELINTA THERAPEUTICS, INC. /NEW/December 20, 201816,007,23728.6%

View OIKOS HOLDINGS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-02
13F-HR2023-11-01
13F-HR2023-08-14
13F-HR2023-04-27
13F-HR2023-01-26
13F-HR2022-11-02
13F-HR2022-07-28
13F-HR2022-04-28
13F-HR2022-01-31

View OIKOS HOLDINGS LLC's complete filings history.

Compare quarters

Export OIKOS HOLDINGS LLC's holdings